Log in to save to my catalogue

Atorvastatin reduces the expression of aldo-keto reductases in HUVEC and PTEC. A new approach to inf...

Atorvastatin reduces the expression of aldo-keto reductases in HUVEC and PTEC. A new approach to inf...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67306115

Atorvastatin reduces the expression of aldo-keto reductases in HUVEC and PTEC. A new approach to influence the polyol pathway

About this item

Full title

Atorvastatin reduces the expression of aldo-keto reductases in HUVEC and PTEC. A new approach to influence the polyol pathway

Publisher

Canada: Canadian Society for Clinical Investigation

Journal title

Clinical and investigative medicine, 2009-06, Vol.32 (3), p.E219-E228

Language

English

Formats

Publication information

Publisher

Canada: Canadian Society for Clinical Investigation

More information

Scope and Contents

Contents

Increased flux of glucose via the polyol pathway, oxidative stress and ischaemia lead to the upregulation of the aldose reductase (AR), the key enzyme of the polyol pathway. This adversely affects the organism and can in part be reduced by inhibition of the enzyme.
In this study, we examined the effect of the HMG-CoA-reductase inhibitor atorvast...

Alternative Titles

Full title

Atorvastatin reduces the expression of aldo-keto reductases in HUVEC and PTEC. A new approach to influence the polyol pathway

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_67306115

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67306115

Other Identifiers

ISSN

1488-2353

E-ISSN

1488-2353

DOI

10.25011/cim.v32i3.6111

How to access this item